scieee Open visual document viewer

Informed consent for paediatric clinical trials in Europe

Lepola, Pirkko,Needham, Allison,Mendum, Jo,Sallabank, Peter,Neubauer, David,de Wildt, Saskia

Abstract

OBJECTIVE: Paediatric clinical trials are often conducted as multinational trials. Informed consent or assent is part of the ethics committee approval for clinical trials. The consent requirements vary between countries due to national laws and regulations, which are not harmonised in Europe. These discrepancies can present challenges for paediatric clinical trials. The aim of this study was to assemble these consent and assent requirements across the European Economic Area. The collated national requirements have not been publicly available before, despite a real need for this data. METHODS: National consent and assent requirements for paediatric clinical trials were analysed and collated for 25 European Union Member States and 2 European Free Trade Association countries until the end of 2014. The data were retrieved from existing databases and through communication with the competent authorities and selected ethics committees. Results from a literature search for international or national guidelines, declarations and conventions and academic societies' publications served as comparison material. RESULTS: Consent and assent requirements are heterogeneous across these countries. We compiled our findings in 'The Informed Consent and Assent Tool Kit', a table including 27 national consent and assent requirements listed by individual country. CONCLUSIONS: Wide variation in paediatric consents and assents presents challenges for multinational paediatric trials in Europe. The toolkit is available for all those involved in paediatric clinical trials and ethics committees, providing a new platform for proactive feedback on informed consent requirements, and may finally lead to a needed harmonisation process, including uniform standards accepted across Europe.

Full text

In o med consen o paedia ic clinical ials in Eu ope Pi kko Lepola, 1,2 Allison Needham, 3 Jo Mendum, 4 Pe e Sallabank, 5 Da id Neubaue , 6 Saskia de Wild 7 1 Finnish In es iga o s Ne wo k o Pedia ic Medicines, Clinical Resea ch Ins i u e Helsinki Uni e si y Cen al Hospi al L d, Helsinki, Finland 2 Tampe e Cen e o Child Heal h Resea ch, 33014 Uni e si y o Tampe e, Tampe e, Finland 3 The Hospi al o Sick Child en Resea ch Ins i u e, To on o, Canada 4 PRA Heal h Sciences, Reading, UK 5 RegulinX, Su bi on, UK 6 Depa men o Child, Adolescen and De elopmen al Neu ology, Uni e si y Child en’s Hospi al/Uni e si y Medical Cen e Ljubljana, Ljubljana, Slo enia 7 Depa men o Pha macology and Toxicology, Radboud Uni e si y, Nijmegen, The Ne he lands Co espondence o M s Pi kko Lepola, Finnish In es iga o s Ne wo k o Pedia ic Medicines, Clinical Resea ch Ins i u e Helsinki Uni e si y Cen al Hospi al, 00290, Helsinki, Finland; pi kko.lepola@u a.fi Recei ed 23 Decembe 2015 Re ised 4 May 2016 Accep ed 9 May 2016 Published Online Fi s 25 May 2016 To ci e: Lepola P, Needham A, Mendum J, e al.A ch Dis Child 2016;101:1017–1025. ABSTRACT Objec i e Paedia ic clinical ials a e o en conduc ed as mul ina ional ials. In o med consen o assen is pa o he e hics commi ee app o al o clinical ials. The consen equi emen s a y be ween coun ies due o na ional laws and egula ions, which a e no ha monised in Eu ope. These disc epancies can p esen challenges o paedia ic clinical ials. The aim o his s udy was o assemble hese consen and assen equi emen s ac oss he Eu opean Economic A ea. The colla ed na ional equi emen s ha e no been publicly a ailable be o e, despi e a eal need o his da a. Me hods Na ional consen and assen equi emen s o paedia ic clinical ials we e analysed and colla ed o 25 Eu opean Union Membe S a es and 2 Eu opean F ee T ade Associa ion coun ies un il he end o 2014. The da a we e e ie ed om exis ing da abases and h ough communica ion wi h he compe en au ho i ies and selec ed e hics commi ees. Resul s om a li e a u e sea ch o in e na ional o na ional guidelines, decla a ions and con en ions and academic socie ies’ publica ions se ed as compa ison ma e ial. Resul s Consen and assen equi emen s a e he e ogeneous ac oss hese coun ies. We compiled ou findings in ‘The In o med Consen and Assen Tool Ki ’, a able including 27 na ional consen and assen equi emen s lis ed by indi idual coun y. Conclusions Wide a ia ion in paedia ic consen s and assen s p esen s challenges o mul ina ional paedia ic ials in Eu ope. The oolki is a ailable o all hose in ol ed in paedia ic clinical ials and e hics commi ees, p o iding a new pla o m o p oac i e eedback on in o med consen equi emen s, and may finally lead o a needed ha monisa ion p ocess, including uni o m s anda ds accep ed ac oss Eu ope. INTRODUCTION Clinical ials (CTs) in child en a e o en conduc ed as mul ina ional, mul icen e ials, necessi a ed by small pa ien popula ions, a i y o disease and limi ed specialis acili ies. As CTs need a sepa a e compe en au ho i y (CA) and e hics commi ee (EC) app o al in each pa icipa ing coun y, he pha maceu ical indus y and in es iga o s spend much ime and esou ces p epa ing documen a ion and co espondence o hese submissions. In Janua y 2007, he Eu opean Union (EU) Paedia ic Regula ion ((Eu opean Commission) No 1901/2006) 1 came in o o ce equi ing he conduc o mo e paedia ic CTs o acili a e he de elop- men and accessibili y o medicinal p oduc s o child en. A u he EU CT Regula ion will come in o o ce a e 28 May 2016, 2 bu while his ha monises he clinical ial applica ion (CTA) p ocess, i does no add ess he di e si y in e iew and conduc o EC app o als a each si e. The p ocess o ob aining EC app o al (wi h consen o assen equi emen s o child en) is no ha monised in he EU. Despi e in e na ionally accep ed e hical p inciples 3–11 and se e al EU-le el guidelines, 12–16 his a ea p esen s a majo challenge o paedia ic CTs ac oss he EU. Al hough he doc- ine o consen is an e hical co ne s one o medical esea ch conduc ed in humans, special p o- isions o child en a y be ween and, in some cases, wi hin coun ies due o di e ences in na ional laws and p ac ices. Wi hin he Eu opean Economic A ea (EEA), h ee egula o y amewo ks go e n he conduc o paedia ic esea ch: he Con en ion on Human Righ s and Biomedicine ( he O iedo Con en ion); 12 Di ec i e 2001/20/EC (Eu opean Wha is al eady known on his opic? ▸The e a e no iceable di e ences be ween na ional consen and assen equi emen s o paedia ic clinical ials in Eu ope due o na ional laws and egula ions. ▸The in e na ional and he e hics socie ies’ guidelines a e no based on uni o m s anda ds and a ely p o ide de ailed consen o assen ecommenda ions o child en. ▸A single sou ce o comp ehensi e mul ina ional da a on in o med consen and assen equi emen s o paedia ic clinical ials ac oss Eu ope is no publicly a ailable. Wha his s udy adds? ▸The ‘In o med Consen and Assen Tool Ki ’is a publicly a ailable esou ce o s akeholde s in ol ed in he unning o paedia ic clinical ials in Eu ope. ▸These da a p o ide a new pla o m o p oac i e eedback om s akeholde s o main ain a common esou ce and app oach o consen and assen equi emen s in Eu ope. ▸These da a hope o p omo e discussion o long- e m decisions and p ac ical changes leading o uni o m e hics commi ee p ocedu es ac oss he Eu opean Economic A ea. Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 1017 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Commission Di ec i e) 14 and he Paedia ic Regula ion ((Eu opean Commission) No 1901/2006). 1 Disc epancies exis be ween hese h ee amewo ks. Fo example, he e o powe o a child o pa icipa e in esea ch is no co e ed in he Paedia ic Regula ion, while he O iedo Con en ion allows a mo e ex ensi e decision-making capaci y by he child han he Eu opean Commission Di ec i e, which elies on in es iga o ’s conside a ion o he explici wish o a child. The aim o his wo k is o desc ibe he he e ogenei y in consen and assen equi emen s o paedia ic CTs and o p o ide a abula ed summa y o hese equi emen s by coun y as a ool o s ake- holde s p epa ing paedia ic CT submissions in he EEA. METHODS The wo king g oup (WG) o he Eu opean Ne wo k o Paedia ic Resea ch a he Eu opean Medicines Agency (Enp -EMA) collec ed specific legal equi emen s o consen and assen o child en and adolescen s om he na ional legisla ions o 25 EU membe s a es and 2 Eu opean F ee T ade Associa ion (EFTA) coun ies (No way and Iceland) du ing 2014. The p ima y da a sou ce was a eposi o y o EC submissions om na ional au ho i ies p o ided by he Con ac Resea ch O ganiza ion (CRO), PRA Heal h Sciences (PRAHS). 17 Seconda y sou ces we e publicly a ailable da a ound on na ional websi es o egula o y au ho i ies, such as Medicines Agencies and Na ional E hics Commi ees. Addi ional da a came h ough Regulinx, 18 a UK-based company specialised in consul - ing on egula o y a ai s, and om he Finnish In es iga o s Ne wo k o Pedia ic Medicines (FinPedMed). 19 Table 1 p o ides a snapsho o he in o ma ion colla ed in 2014. The da a a e a anged by coun y unde h ee main head- ings. The fi s heading, ‘Consen /Assen om child’, includes da a on he legal age o consen and manda o y o sugges ed age anges defined o assen (o consen i assen is no used). The second heading, ‘Consen om pa en (s)/gua dian(s)’, includes legal equi emen s o he numbe o equi ed signa o - ies. The hi d heading, ‘Gene al in o med consen in o ma ion’ includes o ficial language equi emen s and consen empla e(s), guidelines o addi ional na ional in o ma ion wi h exis ing web links. In addi ion, he WG sys ema ically sea ched online sou ces o iden i y subjec - ela ed a icles, lea ned socie ies’ ecommenda- ions and e hical guidelines, con en ions and ecommenda ions. The sea ch was conduc ed in he PubMed (US Na ional Lib a y o Medicine, Na ional Ins i u es o Heal h) da abase, EU Commission websi e, na ional compe en au ho i ies’websi es and Google sou ces using he keywo ds: e hics, guideline, egu- la ions, paedia ic, mino s, child en, biomedical esea ch, clin- ical ials, human igh s and child en’s igh s. The sea ch esul ed in 28 ele an documen s ela ed o medical esea ch e hics on humans and, mo e specifically, on child en. Ten had a wo ldwide scope, nine a con inen al o na ional scope, and nine we e publica ions om academic socie ies. 2–14 20–34 These docu- men s we e compa ed wi h he cu en o ficial and legal ecom- menda ions by e i ying he consen - ela ed and assen - ela ed ex s o hese documen s. Finally, pe sonal expe iences o he WG membe s (ie, in he conduc ed mul icen e ials and communica ion wi h ECs) we e used o supplemen a y compa ison. Once all he da a sou ces o consen and assen equi emen s in he EEA had been colla ed, he WG compa ed and analysed he sou ces o disc epancy in p ac ice ac oss he ju isdic ions. This e ealed se e al disc epancies, which a e add essed in he discussion sec ion. RESULTS Assen and consen : di e ences in use and defini ions Bo h he e m ‘consen ’and ‘assen ’a e in e p e ed di e en ly in legal ex s be ween EEA coun ies. Gene ally, each coun y’s na ional legisla ion includes legal age anges and equi emen s o ei he consen o assen om a child, in addi ion o any legal (pa en al o gua dian) signa u es. The defini ion o hese wo e ms es s on he need o hese signa u es: ei he gi en by he ial subjec alone, o in conjunc ion wi h he pa en s/gua - dians. Usually, consen is defined acco ding o he legal age limi o majo i y, which di e s be ween coun ies. This is no he case in all coun ies, like he Ne he lands whe e in an in o med consen is needed, in addi ion o pa en al consen in child en be ween 12 and 17 yea s o age. Assen is a non-legal ag ee- men , and an addi ional pa en al/gua dian signa u e (consen ) is always equi ed be o e he pa icipa ion o he child in a ial is legally accep ed. Di e ences in consen and assen age limi s and legal signa u es In mos o he EEA coun ies, 18 yea s is he legal age o inde- penden consen , bu he ollowing excep ions should be no ed: 14 yea s in Aus ia, 15 yea s in Finland and Denma k and 16 yea s in he UK. These excep ions come wi h ce ain limi a- ions and wi h he obliga ion o no i y pa en s/legal gua dians. Howe e , ac oss all he EEA coun ies, 32 di e en age g oup- ings o he legal age exis o ecommended addi ional assen o consen needed om he child pa icipa ing in he CT. These g oupings include, o example, 4–11 yea s, 12–14 yea s and 14–17 yea s. Only h ee coun ies (C oa ia, Li huania and Slo akia) ha e no specified age g oups o assen o consen . Di e ences a e also seen in he equi emen o signa u es om pa en s o legal gua dians. Se en een coun ies (63%) equi e signa u es o bo h pa en s in addi ion o he child’sown assen o consen . Specific guidelines wi h consen o m em- pla es and addi ional aid ma e ial (eg, pic u es) o child en in paedia ic CTs ha e been gene ally accep ed by some EU membe s a es (eg, Finland and UK). DISCUSSION The Uni ed Na ions Con en ion on he Righ s o he Child defines a child as e e yone unde 18, unless, ‘unde he law applicable o he child, majo i y is a ained ea lie ’. 3 Fo chil- d en below ha age, he e a e no iceable di e ences be ween na ional and o ganisa ional egula ions on e hical consen in paedia ic CTs. These conce n specifically non-uni o m age limi s and age anges, di e en defini ions o legal consen and he equi emen o pa en al o legal gua dian signa u es. I appea s ha hese c i e ia, o unknown easons, a e no uni o mly defined in Eu opean guidelines o ecommenda ions. We also ound ha he in e na ional and he e hics socie ies’ guidelines and ecommenda ions a ely de ail consen o assen p ocedu es o child en, 71327–31 bu o en e y gene ic ins uc- ions wi hou specificdefini ions. 2–68–12 20–26 32–34 Fo he g ea e pa , hese c i e ia do no seem o be based on he de el- opmen al s age o he child and his/he compe ency le el o in o med consen o assen . Compe ency, in addi ion o heal h condi ion, is impo an o de e mining u he ac ions i ial subjec s each he age o majo i y du ing he s udy and need o gi e hei own (legal) consen o con inue. 2 The e ms ‘consen ’and ‘assen ’a e also no defined in gene al guidelines and a e no ha monised ac oss he EEA. Some Eu opean coun ies use he e m consen o bo h mino s 1018 Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Table 1 The In o med Consen and Assen Tool Ki —in o med consen equi emen s o paedia ic clinical ials in Eu ope Consen /assen om child* Consen om pa en (s)/gua dian(s) Gene al in o med consen in o ma ion Coun y Legal age o consen † Manda o y/sugges ed age anges de ined o assen (o consen i assen no used)‡Numbe o equi ed signa o ies O icial language equi emen s Consen empla e(s)/guidelines/in o ma ion sou ces Aus ia No speci ied P ac ice–– 14 yea s 8–13 yea s EC may equi e younge assen s Bo h pa en s Ge man h p://www.medunig az.a /e hikkommission/Fo um/index.h m h p://www.e hikkommissionen.a / h p://www.uibk.ac.a /s a ech /scheil/ scheil-ein ueh ung-in-die-a zneimi elp ue ung-bei-kinde n-und-jugendlichen---kks--kids-ip.pd Belgium 18 yea s 4–11 yea s (some si es do no use unde 12 yea s) 12–14 yea s 14–17 yea s One pa en a ec ui men , bu bo h pa en s a some poin o signa u es Du ch, F ench; Ge man a si e eques h p://www. agg-a mps.be/en/human_use/medicines/medicines/ esea ch_de elopmen /e hic_ commi ee/ empla es_in o med_consen / Do no ha e paedia ic empla es Bulga ia 18 yea s 6–11 yea s 12–14 yea s 14–17 yea s—use own consen +pa en al signa u e also equi ed Bo h pa en s Bulga ian No na ional EC websi es a ailable in English Bulga ian D ug Agency -> clinical ials h p://en.bda.bg/index.php?op ion=com_ con en & iew=ca ego y&layou =blog&id=14&I emid=34 C oa ia No hing speci ied No hing speci ied No hing speci ied C oa ian Agency o Medicinal P oduc s and Medical De ices o C oa ia -> Cen al E hics Commi ee -> h p://www.almp.h /?ln=en&w=o_SEPu In o ma ion on clinical ials no a ailable in English. Czech Republic 18 yea s 7–11 yea s 12 yea s—own consen 12–14 yea s 15–17 yea s Bo h pa en s. Only by one pa en i he o he pa en is no lis ed in he child’s bi h ce i ica e, has died o is younge han 18 yea s. Czech. Whe e he child’s pa en s (o one o hem) a e o eign na ionals, he in o ma ion shee shall be p esen ed in bilingual o ma . S a e Ins i u e o D ug Con ol -> De ails o clinical ials / Guidelines and Fo ms / KLH-22 V.1: h p://www.sukl.eu/medicines/klh-22- e sion-1 Denma k 18 yea s 15–17 yea s––p oxy consen Bo h pa en s Excep ion—no pa en s i aged 15–17 and non-in e en ional no- isk s udy (EC dispensa ion equi ed) Danish The Na ional Commi ee on Heal h Resea ch E hics -> Guidelines abou no i ica ion h p://www.c k.sum.dk/CVK/Home/English.aspx h p://c k.sum.dk/English/guidelinesabou no i ica ion.aspx -> 4.4. Medicinal p oduc ials and clinical in es iga ions o medicinal de ices in ol ing legally incompe en subjec s; 4.4.1 T ials wi h child en and young people unde he age o 18 h p://c k.sum.dk/English/guidelinesabou no i ica ion.aspx#A sni %205.0 Ac on Resea ch E hics Re iew o Heal h Resea ch P ojec s Es onia 18 yea s 0–7 yea s 7–17 yea s––manda o y Bo h pa en s Es onian S a e Agency o Medicine -> Clinical ials -> Condi ions and p ocedu e o conduc ing clinical ials o medicinal p oduc s h p://www. a imiame .ee/en/clinical- ials-medicinal-p oduc s-es onia Finland 15 yea s W i en sepa a e consen as soon as child is li e a e; unde 15 yea s––own consen +pa en al consen ; 15–17 yea s––own consen +pa en al no i ica ion i mino can unde s and he signi icance o esea ch+di ec heal h bene i is expec ed Pa en o legal gua dian and he child, when hey a e li e a e, need o sign he consen . One pa en by he law, bu he o he one can be in o med (bo h can sign i hey wan ). Finnish, Swedish Medicines Resea ch Ac 488/1999 Medical Resea ch Dec ee 986/1999 Addi ional in o: FinPedMed guidelines; legal and e hical egula ion— empla es o age g oups 6–17 and pa en s Regula o y equi emen s o clinical ials in Finland Pic u e ca ds o suppo IC p ocess Con inued Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 1019 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Table 1 Con inued Consen /assen om child* Consen om pa en (s)/gua dian(s) Gene al in o med consen in o ma ion Coun y Legal age o consen † Manda o y/sugges ed age anges de ined o assen (o consen i assen no used)‡Numbe o equi ed signa o ies O icial language equi emen s Consen empla e(s)/guidelines/in o ma ion sou ces F ance 18 yea s Based on EC—usually wo o h ee age g oups 4–6 yea s 7–12 yea s 13–17 yea s Pic u e ICFs o young child en Bo h pa en s F ench Comi é de P o ec ion des Pe sonnes Sud-Médi e anée II : h p://www.cpp-sudmed2. / In o ma ion-e -au o isa ion-des?lang= Na ional Consul a i e E hics Commi ee o Heal h and Li e Sciences: h p://www.ccne-e hique. /en Ge many 18 yea s 7–11 yea s 12–16 yea s 17 yea s––own consen +pa en al consen equi ed Bo h pa en s Ge man Ge man E hics Council; h p://www.e hik a .o g/—no in o ma ion o clinical ials Landesä z ekamme B andenbu g—in o ma ion a ailable ONLY in Ge man. h ps://www.laekb.de/ ICF Guidance h ps://www.laekb.de/ iles/146A97FF999/AMG_Pa ien enin o_Kinde _7bis11.pd Hunga y 18 yea s Unde 6 yea s 6–10 yea s 11–14 yea s 15–17 yea s One pa en Hunga ian Na ional Ins i u e o Pha macy and Nu i ion -> Laws and egula ions (only a ailable in Hunga ian) -> Minisz e i endele ek h p://ogyei.go .hu/sea ch/index.php?sea chPh ase=dec ee& om=10 h p://www.ogyei.go .hu/magya _jogszabalyok/ -> Dec ee 35/2005 (VIII. 26.) o he Minis e o Heal h on he clinical ial and applica ion o co ec clinical p ac ices o in es iga ional medicinal p oduc s in ended o use in humans 7§ Clinical ials conduc ed on mino s h p://ne .jog a .hu/j /gen/ge doc.cgi?docid=A0500035.eum Iceland 18 yea s Unde 12 yea s One pa en — he EC can eques bo h pa en s’signa u es in some cases. Icelandic o English. The s udy objec i e in Icelandic. Ma e ials in Icelandic. (Fo s udies in ol ing g oups o o he e hnici y, an app op ia e language is equi ed.) The Na ional Bioe hics Commi ee (h p://www. sn.is/en/node/189) The Pa liamen ; h p://www.al hingi.is/english -> h p://www.al hingi.is/lagasa n/ log-sam hykk -a-al hingi/ -> The Ac o Law, No. 44/2014, on scien i ic esea ch wi hin he heal h sec o de ines he condi ions o biomedical esea ch and he ole o he bioe hics commi ees h p://www.al hingi.is/lagas/nuna/2014044.h ml Se e al laws and egula ions on da a p o ec ion, medicines, biobanks and heal h in o ma ion collec ions (2014), e c I eland 16 yea s (clinical ials) 18 yea s (all o he esea ch) 7 yea s, o acco ding o capaci y o child One pa en English Lis o Resea ch E hics Commi ees o clinical ials o IMP: h p://heal h.go .ie/ eu opean-communi ies-clinical- ials-on-medicinal-p oduc s- o -human-use- egula ions-2004/ Resea ch E hics Commi ee S anda d Applica ion Fo m: h p://www.molecula medicinei eland.ie/ esea ch_e hics Na ional Consen Policy: h p://www.hse.ie/eng/abou /Who/quali yandpa ien sa e y/Na ional_ Consen _Policy/consen aine esou ce/ aine iles/Na ionalConsen PolicyDOC.h ml Clinical T ial Regula ion: S.I. No. 190/2004—Eu opean Communi ies (Clinical T ials on Medicinal P oduc s Fo Human Use) Regula ions, 2004 h p://www.i ishs a u ebook.ie/2004/en/si/0190.h ml Con inued 1020 Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Table 1 Con inued Consen /assen om child* Consen om pa en (s)/gua dian(s) Gene al in o med consen in o ma ion Coun y Legal age o consen † Manda o y/sugges ed age anges de ined o assen (o consen i assen no used)‡Numbe o equi ed signa o ies O icial language equi emen s Consen empla e(s)/guidelines/in o ma ion sou ces I aly 18 yea s 6–10 yea s 11–14 yea s 15–17 yea s––wi h own signa u e No o icial manda o y age(s) o assen . Di e en age- ailo ed assen s a e submi ed olun a ily, and a e e alua ed by he ECs Bo h pa en s I alian The I alian Medicines Agency h p://www.agenzia a maco.go .i /en/con en /clinical- ials he I alian egula ion on CTs include he ollowing: D.lgs 211/2003 h p://www.agenzia a maco.go .i /si es/de aul / iles/dec e o_24062003_inglese. pd DM 21/12/07 h ps://www.agenzia a maco.go .i / icclin/si es/de aul / iles/ iles_wysiwyg/ iles/ No ma i a/MD_21_Decembe _2007_CTA o m_English.pd La ia 18 yea s 0–7 yea s 7–17 yea s One pa en o legal ep esen a i e La ian S a e Agency o Medicines o he Republic o La ia -> Clinical ials and non-in e en ional ials -> legisla ion h p://www.z a.go .l /?se lang=en -> h p://www.z a.go .l /?id=396&sa=396& op=386 -> h p://www.z a.go .l /index.php?id=381&sa=381& op=333&lang h p://www.z a.go .l /doc_upl/MK_no _289_English_02062010.pd Li huania 18 yea s No se ages Bo h pa en s Li huanian The Li huanian Bioe hics Commi ee -> Biomedical Resea ch -> a ou able opinion on clinical d ug ial h p://bioe ika.sam.l /index.php?3202747546 In o med Consen h p://bioe ika.sam.l /index.php?3221858831 -> h p://bioe ika.sam.l /index.php?577320631—in o ma ion a ailable only in Li huanian h p://bioe ika.sam.l /index.php?3202747546 Mal a 18 yea s 6–17 yea s Pa en s o legal ep esen a i e P ac ice—bo h pa en s One o he o icial languages o Mal a (eg, Mal ese) o in a language unde s andable o he clinical ial subjec and/o his legal ep esen a i e. Mal a Heal h E hics Commi ee h ps://heal h.go .m /en/appbodies/hec/Pages/Links.aspx Mal ese Clinical T ials Regula ions 2004 (LN490 o 2004) MEDICINES ACT, 2003 (ACT NO. III OF 2003); h p://jus icese ices.go .m /DownloadDocumen .aspx?app=lp&i emid=16860&l=1 The Ne he lands 18 yea s 12–17 yea s Bo h pa en s. I pa en s a e di o ced and hey bo h ha e pa en al igh s, hey bo h ha e o sign. Fo a single pa en , wi hou ano he pa ne wi h pa en al igh s, one signa u e is enough. Du ch Cen al Commi ee on Resea ch In ol ing Human Subjec s (CCMO) -> Human Subjec -> In o med Consen —in o ma ion a ailable only in Du ch. h p://www.ccmo.nl/en/ -> h p://www.ccmo.nl/en/mino s Con inued Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 1021 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Table 1 Con inued Consen /assen om child* Consen om pa en (s)/gua dian(s) Gene al in o med consen in o ma ion Coun y Legal age o consen † Manda o y/sugges ed age anges de ined o assen (o consen i assen no used)‡Numbe o equi ed signa o ies O icial language equi emen s Consen empla e(s)/guidelines/in o ma ion sou ces No way 18 yea s 16–17 yea s––wi h own signa u e 12–16 yea s––in special ci cums ances Main ule: bo h pa en s sign he consen o m i hey ha e pa en al esponsibili y o he child. Requi ed o all child en unde 12 yea s old. No wegian The No wegian Na ional Resea ch E hics Commi ees -> Clinical T ials -> Regula ions h ps://www.e ikkom.no/en/e hical-guidelines- o - esea ch/ h p://www.legemiddel e ke .no/English/Clinical_ ials/Regula ions/Documen s/No wegian% 20 egual ion%20 o %20Clinical%20T ials.pd Na ional da abase o Laws and Ac s -> Lo om medisinsk og helse aglig o skning (helse o skningslo en)—in o ma ion a ailable only in No wegian. h ps://lo da a.no/dokumen /NL/lo /2008-06-20-44?q=helse o skning Ac on medical and heal h esea ch (Helse o sknings-lo en) Guidance o Helse o sknings-lo en (in No wegian only) Addi ional in o: No wegian Medicines Agency: Websi e on clinical ials. Poland 18 yea s 6–11 yea s 12–15 yea s 16–17 yea s One pa en P ac ice—bo h pa en s Polish h p://www.eu ecne .o g/in o ma ion/poland.h ml No na ional EC websi es a ailable in English Po ugal 18 yea s 0–8 yea s 8–12 yea s 12–17 yea s Bo h pa en s Po uguese h p://www.eu ecne .o g/in o ma ion/po ugal.h ml CEIC—Na ional E hics Commi ee o Clinical Resea ch h p://www.in a med.p /po al/page/po al/CEIC/English No na ional egula ions/ac s a ailable in English Romania 18 yea s Unde 6 yea s 6–10 yea s 11–14 yea s 15–18 yea s Bo h pa en s Romanian Na ional E hics Commi ee o Romania h p://www.adsm. o/ o/comisia+na ionala+de+bioe ica+a+medicamen ului+si+a+dispozi i elo +medicale# No in o ma ion a ailable in English Sco land (UK) 16 yea s 0–5 yea s 6–10 yea s 11–15 yea s Consen wi h own signa u e unde 16 yea s, i hey a e compe en o do so One pa en English NRES Guidance h p://www.h a-decision ools.o g.uk/consen /p inciples-child en.h ml and h p://www.ukc g.nih .ac.uk/de aul .aspx Slo akia n.a. n.a. n.a. Slo akian The S a e Ins i u e o D ug Con ol (SIDC) -> Clinical ials -> Ins uc ions h p://www.sukl.sk/en?page_id=256 -> h p://www.sukl.sk/en/clinical- ials/ins uc ions?page_id=2821 No na ional egula ions/ac s a ailable in English Slo enia 18 yea s 9 yea s—assen 15 yea s—wi h own signa u e One pa en Slo enian Republic o Slo enia Na ional Medical E hics Commi ee -> h p://kme-nmec.si/—only on page No addi ional in o ma ion a ailable. Spain 18 yea s 0–11 yea s 12–17 yea s––wi h own signa u e One pa en Spanish The Agencia Española de Medicamen os y P oduc os Sani a ios (AEMPS); A s a e agency wi hin he Spanish Minis y o Heal h, Social Se ices and Equali y -> Medicines o Human use—> Clinical esea ch wi h medicines h p://www.aemps.gob.es/en/in es igacionClinica/medicamen os/home.h m The Minis y o Heal h, sec ion abou egula ion o clinical ials: h p://www.aemps.gob.es/en/legislacion/espana/in es igacionClinica/ensayos.h m The Spanish Regula ion abou Clinical ials: he ROYAL DECREE 223/2004-sec ion 7.3 (English e sion is a ailable by eques ) Con inued 1022 Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om Table 1 Con inued Consen /assen om child* Consen om pa en (s)/gua dian(s) Gene al in o med consen in o ma ion Coun y Legal age o consen † Manda o y/sugges ed age anges de ined o assen (o consen i assen no used)‡Numbe o equi ed signa o ies O icial language equi emen s Consen empla e(s)/guidelines/in o ma ion sou ces Sweden 18 yea s W i en sepa a e consen as soon as child is li e a e 6–10 yea s 11–14 yea s 15–17 yea s––wi h own signa u e Bo h pa en s and he child, when li e a e, need o sign he consen Swedish The Cen al E hical Re iew Boa d -> Documen s -> In o ma ion o Resea ch Pa icipan s h p://www.epn.se/en/s a / he-o ganisa ion/ -> h p://www.epn.se/en/s a / cen al-e hical- e iew-boa d-documen s/ -E ikp ö ningslagen 2008. Regula o y equi emen o clinical ials LVFS 2011:19 Läkemedelslagen—1992 Biobank law––2002 Pe sonal Da a Ac 1998 Na ional Medicines Agency -> Legisla ion -> Codes o S a u es -> 1996:17 Clinical ials o medicinal p oduc s h ps://lakemedels e ke .se/english/ -> h ps://lakemedels e ke .se/english/o e iew/Legisla ion/ Codes-o -s a u es/ UK 16 yea s 0–5 yea s 6–10 yea s 11–15 yea s One pa en English NRES Guidance; h p://www.h a-decision ools.o g.uk/consen /p inciples-child en.h ml and h p://www.ukc g.nih .ac.uk/de aul .aspx © Eu opean Medicines Agency, 2015. Rep oduced wi h pe mission *Consen /assen om child: his in o ma ion has been mainly collec ed ia he no mal daily wo k and no es o he CRO Company, PRA Heal h Sciences (UK), when p epa ing EC submissions o na ional au ho i ies. Some o his in o ma ion is no a ailable in English, no publicly a ailable in egula o y au ho i y’s web pages. In addi ion, some English- ansla ed ex e sions may include inaccu a e e ms o explana ions, which could gi e ise o di e en in e p e a ions. The e o e, he au ho s canno gua an ee 100% accu acy o all na ional equi emen s. In addi ion, his able is a snapsho o he da a ga he ed in 2014, which migh ha e subsequen ly changed. †Legal age o consen : legal age o consen means he age om which a child is able o gi e and sign hei own independen legally alid consen acco ding o he na ional law/ac / egula ion. Child en below his age limi a e incapable o gi ing legal in o med consen and need pa en al/legally au ho ised gua dian’s in o med consen wi h a signa u e o pa icipa e in a clinical s udy. Pa en al/legally au ho ised gua dian’s in o med consen may be ob ained/sough in addi ion o he child’s own consen / assen , o when he child abo e he age limi is incapable o sign consen due o a di icul physical condi ion. ‡Manda o y/sugges ed age anges de ined o assen (o consen i assen no used): hese manda o y o sugges ed age anges a e de ined in na ional egula ion/law/ac , o a child below he legal age o consen and o own in o med consen o assen (depending on he e minology used in legal ex s). This consen o assen is ob ained in addi ion o he legally alid pa en al/legally au ho ised gua dian’s signed in o med consen . This ype o child’s own assen /consen suppo s he child’s in eg i y and igh s, c ea es he oppo uni y o hea hei own opinion, supposed will and possible dissen , hus espec ing he child’s au onomy in he in o med consen p ocess. Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 1023 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om (olde child en below legal adul age) and pa en s (legal gua - dians). Usually, he e m assen e e s o a child’s o mino ’s ag eemen o he ial (no legally alid on i s own), while consen is documen ed h ough legal signa u e(s) by he pa en s (gua dians) o he child, when he child is abo e he legal age. The e a e mo e han 1000 ECs in Eu ope, 35 which esul in subs an ial a iabili y o EC composi ions and p ac ices, 36–38 wi h consequen ly a ce ain deg ee o inconsis ency in he equi ed consen and assen documen a ion o mul ina ional and mul icen e ials. Mo eo e , much ime and esou ces may be needed o ob ain app o als. To manage hese inconsis encies and o educe he duplica i e wo kload, sponso s a e ecom- mended o pe o m an i e a i e o sequen ial e iew a each pa - icipa ing ins i u ion o coun y. The Eu opean Medicines Agency (EMA) has e alua ed he impac o he Paedia ic Regula ion a e i s fi s 5 yea s o being in o ce. 39 So a , he egula ion has no ye led o mo e paedia - ic CTs in Eu ope, al hough he e a e plans o conduc CTs wi h en olmen o mo e child en. 39 S ill, he ini ia ion o new CTs may be hampe ed by he p ac ical obs acles o complex EC p ocesses. Cu en ly, i is no possible o seek Eu opean-wide legisla i e changes o EC p ac ice ha monisa ion, as he p ac ice o one EC will no necessa ily wo k o ano he wi hou conce ed e o o achie e ha mony. Howe e , an expe g oup has designed model consen and assen o ms o di e en paedia - ic age g oups, 40 which could be applied ac oss Eu ope. Fu he mo e, be e defini ions o he concep s o ‘unde s and- ing’,‘capabili y’,‘capaci y o au onomous decisions’and ‘mo al unde s anding o al uism’could g ea ly suppo a ha - monisa ion p ocess. To sol e hese p oblems, we sugges he ollowing measu es: ▸Uni o m, commonly accep ed s anda ds and guidance ac oss Eu ope/EEA ▸Defini ion o he lowes age limi o consen and assen equi ing own signa u es in addi ion o pa en al (legal) consen un il he legal age o majo i y pe mi s independen consen ▸Fundamen al discussion o c ea e mo e de ailed defini ions o assen and consen and o decide whe he hese e ms could be ha monised and used wi h simila p inciples o paedia ic popula ion ▸S anda dised s uc u e and eading le el equi emen s o consen and assen documen s, including ecommenda ions o legal gua dian’s (pa en al) signa u es ▸A mas e consen /assen empla e in all na ional languages being publicly and eadily a ailable. ‘The In o med Consen and Assen Tool Ki ’was upda ed mainly un il he end o 2014. As na ional-le el egula ions and laws may change o e di e en in e als, he accu acy o he da a and linked documen s a e dependen upon egula e iew. The Enp -EMA’s cen al aim is o enhance and p omo e he conduc o paedia ic CTs in Eu ope. This oolki being publicly a ailable ee o cos on he Enp -EMA websi e mee s his aim. Please go o: h p://www.ema.eu opa.eu/Pa ne s&Ne wo ks/ Ne wo ks/Enp -EMA/Enp -EMA ac i i ies, o di ec ly a : h p:// inyu l.com/h2x l . Wi h his oolki , we hope ha all s ake- holde s will p oac i ely p o ide eedback ia he Enp -EMA, o keep his oolki up o da e and os e ing discussion on ha mon- isa ion o EC p ocedu es needed o paedia ic ials ac oss Eu ope. Acknowledgemen s Special hanks go ou o o he pa ne s o ou o iginal wo king g oup, I ana Sil a (EMA), D Richa d T ompe e (GOSH/IPTA, UK) and D Alan Boddy (p e iously Newcas le Uni e si y/cu en ly, he Uni e si y o Sydney) o hei help in p epa ing he ini ial epo o Enp -EMA. Con ibu o s Li e a u e sea ch was done by PL, AN, JM, PS and DN; da a collec ion and figu es we e done by PL, JM, PS and AN; Da a in e p e a ion, w i ing and app o al o final e sion we e done by all au ho s. Funding This esea ch has ecei ed unding om he Eu opean Union’s Se en h F amewo k P og amme o esea ch, echnological de elopmen and demons a ion unde g an ag eemen no. 261060 (Global Resea ch in Paedia ics—GRiP ne wo k o excellence). Compe ing in e es s None decla ed. P o enance and pee e iew Commissioned; ex e nally pee e iewed. Open Access This is an Open Access a icle dis ibu ed in acco dance wi h he C ea i e Commons A ibu ion Non Comme cial (CC BY-NC 4.0) license, which pe mi s o he s o dis ibu e, emix, adap , build upon his wo k non-comme cially, and license hei de i a i e wo ks on di e en e ms, p o ided he o iginal wo k is p ope ly ci ed and he use is non-comme cial. See: h p://c ea i ecommons.o g/ licenses/by-nc/4.0/ REFERENCES 1 Eu opean Union. Regula ion (EC) No 1901/2006 o he Eu opean Pa liamen and o he Council o 12 Decembe 2006 on medicinal p oduc s o paedia ic use and amending Regula ion (EEC) No 1768/92, Di ec i e 2001/20/EC, Di ec i e 2001/83/ EC and Regula ion (EC) No 726/2004. 26 Janua y 2007. h p://ec.eu opa.eu/heal h/ files/eud alex/ ol-1/ eg_2006_1901/ eg_2006_1901_en.pd (accessed 16 Dec 2014). 2 Eu opean Union. Regula ion EU No 536/2014 o he Eu opean Pa liamen and o he Council o 16 Ap il 2014 on clinical ials on medicinal p oduc s o human use, and epealing Di ec i e 2001/20/EC. 16 June 2014 (will become applicable no ea lie han 28 May 2016). h p://ec.eu opa.eu/heal h/human-use/clinical- ials/ egula ion/index_en.h m (accessed 16 Dec 2014). 3 Uni ed Na ions Human Righ s. Con en ion on he Righ s o he Child. Adop ed and opened o signa u e, a ifica ion and accession by Gene al Assembly esolu ion 44/ 25 o 20 No embe 1989, en y in o o ce 2 Sep embe 1990, in acco dance wi h a icle 49. 1990. h p://www.ohch .o g/en/p o essionalin e es /pages/c c.aspx (accessed 15 Dec 2014). 4 Uni ed Na ions. The Uni e sal Decla a ion o Human Righ s. 1948. h p://www.un. o g/en/documen s/udh / (accessed 15 Dec 2014). 5 Wo ld Medical Associa ion. WMA Decla a ion o Helsinki—E hical P inciples o Medical Resea ch In ol ing Human Subjec s. 64 h WMA Gene al Assembly, Fo aleza, B azil, Oc obe 2013. h p://www.wma.ne /en/30publica ions/10policies/ b3/ (accessed 15 Dec 2014). 6 In e na ional Con e ence o Ha moniza ion. ICH Guideline o good Clinical P ac ice E6 (R1). 1996. h p://www.ich.o g/p oduc s/guidelines/e ficacy/a icle/ e ficacy-guidelines.h ml (accessed 16 Dec 2014). 7 In e na ional Con e ence o Ha moniza ion. ICH E 11- Clinical In es iga ion o Medicinal P oduc s in he Paedia ic Popula ion. 2000. h p://www.ich.o g/p oduc s/ guidelines/e ficacy/a icle/e ficacy-guidelines.h ml (accessed 16 Dec 2014). 8 The Council o In e na ional O ganiza ions o Medical Sciences (CIOMS) in collabo a ion wi h he Wo ld Heal h O ganiza ion (WHO)—In e na ional E hical Guideline o Biomedical Resea ch In ol ing Human Subjec s. 2002. h p://www. cioms.ch/publica ions/layou _guide2002.pd (accessed 15 Dec 2014). 9 Wo ld Heal h O ganiza ion. WHO Guidelines o good clinical p ac ice (GCP) o ials on pha maceu ical p oduc s. Technical Repo Se ies, No. 850, 1995, Annex 3. 1995. h p://www.nus.edu.sg/i b/A icles/WHO%20GCP%201995.pd (accessed 15 Dec 2014). 10 Wo ld Heal h O ganiza ion. WHO Handbook o Good Clinical Resea ch P ac ice (GCP) Guidance o Implemen a ion. 2002. h p://apps.who.in /p equal/in o_gene al/ documen s/GCP/gcp1.pd (accessed 15 Dec 2014). 11 Uni ed Na ions Educa ional, Scien ific and Cul u al O ganiza ion. UNESCO Uni e sal Decla a ion on Bioe hics and Human Righ s. Adop ed by acclama ion by he 33 d session o he Gene al Con e ence o UNESCO on 19 Oc obe 2005. h p://www. unesco.o g/new/en/social-and-human-sciences/ hemes/bioe hics/ bioe hics-and-human- igh s/ (accessed 15 Dec 2014). 12 Council o Eu ope—ETS no.164—Con en ion o he P o ec ion o Human Righ s and Digni y o he Human Being wi h ega d o he Applica ion o Biology and Medicine: Con en ion on Human Righ s and Biomedicine. O iedo, 4.IV.1997. h p:// con en ions.coe.in /T ea y/en/T ea ies/H ml/164.h m (accessed 15 Dec 2014). 13 Eu opean Union Commission ad hoc g oup. Recommenda ions o he Ad hoc g oup o he de elopmen o implemen ing guidelines o Di ec i e 2001/20/EC ela ing o good clinical p ac ice in he conduc o clinical ials on medicinal p oduc s o human use. E hical Conside a ions o Clinical T ials on Medicinal P oduc s Conduc ed wi h he Paedia ic Popula ion. 06 Oc obe 2008. h p://ec.eu opa.eu/ heal h/files/paedia ics/docs/paeds_e hics_consul a ion20060929_en.pd (accessed 9 Feb 2015). 1024 Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om 14 EU Commission. Di ec i e 2001/20/EC o he Eu opean Pa liamen and o he Council o 4 Ap il 2001 on he app oxima ion o he laws, egula ions and adminis a i e p o isions o he Membe S a us ela ing o he implemen a ion o good clinical p ac ice in he conduc o clinical ials on medicinal p oduc s o human use. O ficial Jou nal o he Eu opean Communi ies 2011. L 121/34–44. h p://ec.eu opa.eu/heal h/human-use/clinical- ials/di ec i e/index_en.h m (accessed 16 Dec 2014). 15 Eu opean Commission. Eud aLex—Volume 10 Clinical ials guidelines, Chap e I: Applica ion and Applica ion Fo m; De ailed guidance on he applica ion o ma and documen a ion o E hics Commi ees opinion. Feb ua y 2006. h p://ec.eu opa.eu/ heal h/documen s/eud alex/ ol-10/index_en.h m (accessed 16 Dec 2014). 16 Eu opean Commission. En e p ise and Indus y Di ec o a e-Gene al, Consume goods, Pha maceu icals. De ailed guidance on he applica ion o ma and documen a ion o be submi ed in an applica ion o an E hics Commi ee opinion on he clinical ial on medicinal p oduc s o human use, Feb ua y 2006. h p://ec.eu opa.eu/heal h/files/eud alex/ ol-10/12_ec_guideline_ 20060216_en.pd 17 PRA Heal h Sciences In e na ional, h p://p ahs.com/ (accessed 9 Feb 2015). 18 Regulinx, UK, h p://www. egulinx.eu/ (accessed 9 Feb 2015). 19 FinPedMed, Finland, h p://www.finpedmed.fi/index.php?page=107&lang=2 (accessed 9 Feb 2015). 20 Heal h Canada—Requi emen s o In o med Consen . 2014. h p://www.hc-sc.gc.ca/ s -s /ad ice-a is/ eb-ce /consen /index-eng.php (accessed 16 Dec 2014). 21 U.S. Depa men o Heal h and Human Se ices, U.S. Food and D ug Adminis a ion —CFR Code o Fede al Regula ions, Ti le 21; Pa s 50, 201 and 814. 50. h p:// www.accessda a. da.go /sc ip s/cd h/c docs/c c /CFRSea ch.c m?CFRPa =50, 201 h p://www.accessda a. da.go /sc ip s/cd h/c docs/c CFR/CFRSea ch.c m? CFRPa =201, 814 h p://www.accessda a. da.go /sc ip s/cd h/c docs/c c / CFRSea ch.c m?CFRPa =814 (accessed 16 Dec 2014). 22 Medical Resea ch Council (MRC) E hics Guide. Medical esea ch in ol ing child en. UK Medical Resea ch Council 2004. h p://www.m c.ac.uk/documen s/pd / medical- esea ch-in ol ing-child en/ (accessed 9 Feb 2015). 23 Canada, T.G.o. TCPS 2—2nd edi ion o T i-Council Policy S a emen :E hical Conduc o Resea ch In ol ing Humans, 2010. h p://www.p e.e hics.gc.ca/eng/ policy-poli ique/ini ia i es/ cps2-ep c2/de aul / 24 U.S. Depa men o Heal h and Human Se ices. Basic HHS Policy o P o ec ion o Human Resea ch Subjec s (“The Common Rule”) 45CFR46. 25 Field MJ, Beh man RE, Ins i u e o Medicine (US) Commi ee on Clinical Resea ch In ol ing Child en. E hical Conduc o Clinical Resea ch In ol ing Child en. Washing on DC: Na ional Academies P ess (US), 2004. 26 Van’ Ho W., O inga M, o he S a Child Heal h g oup. S aR Child Heal h: de eloping e idence-based guidance o he design, conduc and epo ing o paedia ic ials. A ch Dis Child 2015;100:189–92. 27 Shaddy RE, Denne S. C, he Commi ee on D ugs and Commi ee on Pedia ic Resea ch o he Ame ican Academy o Pedia ics. Guidelines o he E hical Conduc o S udies o E alua e D ugs in Pedia ic Popula ions. Guidelines o he E hical Conduc o S udies o E alua e D ugs in Pedia ic Popula ion. Pedia ics 2010:,125:;850–60. 28 De Lou des Le y M, La che V, Ku z R, E hics Wo king G oup o he Con ede a ion o Eu opean Specialis s in Paedia ics (CESP). In o med consen /assen in child en. S a emen o he E hics Wo king G oup o he Con ede a ion o Eu opean Specialis s in Paedia ics (CESP). Eu J Pedia 2003;162:629–33. 29 Modi N, Voh a J, P es on J, e al., Wo king Pa y o he Royal College o Paedia ics and Child Heal h. Guidance on clinical esea ch in ol ing in an s, child en and young people: an upda e o esea che s and esea ch e hics commi ees. A ch Dis Child 2014;99:887–91. 30 Gill D, E hics Wo king G oup o he Con ede a ion o Eu opean Specialis s in Paedia ics. E hical p inciples and ope a ional guidelines o good clinical p ac ice in paedia ic esea ch. Recommenda ions o he E hics Wo king G oup o he Con ede a ion o Eu opean Specialis s in Paedia ics (CESP). Eu J Pedia 2004;163:53–7. 31 McIn osh N. Child Heal h: E hics Ad iso y Commi ee, Royal College o Paedia ics. Guidelines o he e hical conduc o medical esea ch in ol ing child en. A ch Dis Child 2000;82:177–82. 32 Gill D, C awley FP, LoGiudice M, e al. E hics Wo king G oup o he Con ede a ion o Eu opean Specialis s in Pedia ics. Guidelines o in o med consen in biomedical esea ch in ol ing paedia ic popula ions as esea ch pa icipan s. Eu J Pedia 2003;162:455–8. 33 Saue PJ, E hics Wo king G oup, Con ede a ion o Eu opean Specialis s in Paedia ics (CESP). Resea ch in child en. A epo o he E hics Wo king G oup o he CESP. Eu J Pedia 2002;161:1–5. 34 ERIC Compendium. E hical Resea ch In ol ing Child en; E hical Guidance: In o med Consen , 2013. h p://childe hics.com/wp-con en /uploads/2013/10/ ERIC-compendium-E hical-Guidance-In o med-consen -sec ion-only.pd (accessed 25 Feb 2015). 35 Al a illa A, Man edi C, Baia di P, e al. Impac o he new eu opean paedia ic egula o y amewo k on e hics commi ees: o e iew and pe spec i es. Ac a Paedia 2012;101:e27–32. 36 He nandez R, Cooney M, Dualé C, e al. Ha monisa ion o e hics commi ees’ p ac ice in 10 Eu opean coun ies. J Med E hics 2009;35:696–700. 37 Vee us P, Lexchin J, Hemminki E. Legisla i e egula ion and e hical go e nance o medical esea ch in di e en Eu opean Union coun ies. J Med E hics 2014;40:409–13. 38 Legisla ion on bio echnology in he No dic coun ies—an o e iew 2014. No dFo sk, 2014 S ensbe gga a 25 N–0170 Oslo, h p://www.no d o sk.o g. ISSN 1504-8640 h p://www.no d o sk.o g/en/publica ions/publica ions_con aine / legisla ion-on-bio echnology-in- he-no dic-coun ies-2013-an-o e iew-2014/ iew (accessed 11 Dec 2014). 39 5-yea Repo o he Eu opean Commission. Gene al epo on he expe ience acqui ed as a esul o he applica ion o he Paedia ic Regula ion. 8 July 2012, EMA/428172/2012, Human Medicines De elopmen and E alua ion Human Medicines Special A eas Sec o . h p://ec.eu opa.eu/heal h/files/paedia ics/2012-09_ pedia ic_ epo -annex1-2_en.pd (accessed 13 Dec 2013). 40 FINPEDMED: Documen empla es. T ial In o ma ion and in o med consen documen empla es. h p://www.finpedmed.fi/index.php?page=1255&lang=2 (accessed 25 Feb 2015). Lepola P, e al.A ch Dis Child 2016;101:1017–1025. doi:10.1136/a chdischild-2015-310001 1025 O iginal a icle g oup.bmj.com on No embe 30, 2016 - Published by h p://adc.bmj.com/Downloaded om